Ogilvie

From WikiMD's WELLNESSPEDIA

Ogilvie's syndrome or Ogilvie disease is a rare, short-term condition that affects the colon. It is characterized by an abnormal dilation or enlargement of the colon, which can lead to severe abdominal pain, bloating, and constipation. The condition is named after the British surgeon Sir William Heneage Ogilvie, who first described it in 1948.

Symptoms[edit]

The most common symptoms of Ogilvie's syndrome include:

  • Severe abdominal pain
  • Bloating
  • Constipation
  • Nausea and vomiting
  • Distention of the abdomen

Causes[edit]

The exact cause of Ogilvie's syndrome is unknown. However, it is often associated with certain medical conditions and treatments, including:

Diagnosis[edit]

Diagnosis of Ogilvie's syndrome is typically based on the patient's symptoms and medical history, as well as the results of certain tests. These tests may include:

Treatment[edit]

Treatment for Ogilvie's syndrome typically involves managing the symptoms and addressing the underlying cause, if known. This may include:

  • Medications to reduce the size of the colon and improve bowel function
  • Surgery, in severe cases
  • Dietary changes, such as increasing fiber intake

Prognosis[edit]

The prognosis for Ogilvie's syndrome is generally good, with most patients recovering fully with appropriate treatment. However, complications can occur if the condition is not treated promptly, including perforation of the colon and sepsis.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.